A detailed history of D. E. Shaw & Co., Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 109,943 shares of GH stock, worth $3.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
109,943
Previous 136,029 19.18%
Holding current value
$3.12 Million
Previous $3.68 Million 38.35%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$17.13 - $26.91 $446,853 - $701,974
-26,086 Reduced 19.18%
109,943 $2.27 Million
Q4 2023

Feb 14, 2024

SELL
$21.58 - $29.5 $1.94 Million - $2.66 Million
-90,063 Reduced 39.83%
136,029 $3.68 Million
Q3 2023

Nov 14, 2023

BUY
$25.8 - $39.97 $5.83 Million - $9.04 Million
226,092 New
226,092 $6.7 Million
Q1 2023

May 15, 2023

BUY
$22.92 - $33.76 $11.2 Million - $16.6 Million
490,671 New
490,671 $11.5 Million
Q2 2022

Aug 15, 2022

BUY
$28.82 - $77.35 $270,908 - $727,090
9,400 New
9,400 $379,000
Q4 2021

Feb 14, 2022

SELL
$88.71 - $120.43 $6.35 Million - $8.62 Million
-71,604 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $15.5 Million - $20.8 Million
-157,128 Reduced 68.7%
71,604 $8.95 Million
Q2 2021

Aug 16, 2021

SELL
$109.77 - $165.68 $4.39 Million - $6.62 Million
-39,970 Reduced 14.88%
228,732 $28.4 Million
Q1 2021

May 17, 2021

BUY
$127.04 - $179.1 $28.5 Million - $40.2 Million
224,549 Added 508.57%
268,702 $41 Million
Q4 2020

Feb 16, 2021

BUY
$99.96 - $135.93 $3.32 Million - $4.52 Million
33,248 Added 304.89%
44,153 $5.69 Million
Q3 2020

Nov 16, 2020

BUY
$80.32 - $111.8 $875,889 - $1.22 Million
10,905 New
10,905 $1.22 Million
Q2 2020

Aug 14, 2020

SELL
$60.49 - $97.5 $640,407 - $1.03 Million
-10,587 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$59.04 - $88.81 $625,056 - $940,231
10,587 New
10,587 $737,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.9B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.